# M/VENTURES: portfolio, investments and team

> M/VENTURES is a vc firm based in France. 20 investments on record, 4 in the last 12 months, latest Oct 2026. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/m-ventures-6 (Millionrounds; every figure on the page links to its filing or article)

France · [Investor](https://millionrounds.com/investors)

# M/VENTURES

Last cheque observed Oct 2026; 20 cheques on record.

Email

VC firm Deploying now Last fund, Jan 2018

Series A Series B Growth Venture Capital & Private Equity

Follow M/VENTURES and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fm-ventures-6)

Deploying now

**100%** of best year **4** **cheques in 12 months**, 20 on record

Since the last cheque **17** days **00** hrs **00** min **00** sec

Median round **$29M** Rounds led **6 of 20** Sole investor **1 rounds** Mostly in **United States, 63%**

Pitch M/VENTURES

Another investor of this name exists, and we could not establish from the rounds which of them the press meant. Treat the record below as possibly belonging to either. [Tell us which](https://millionrounds.com/corrections?slug=m-ventures-6) if you know.

## M/VENTURES highlights

- 01 4 cheques in the last 12 months
- 02 Mostly Series A and Series B: 89% of its rounds
- 03 Sole investor in 1 rounds, median $16M

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Venture Capital & Private Equity
- **Based in:** Toulouse, France
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **20 appearances**

- **2026** 3 rounds
- **Oct** **[Nouscom](https://millionrounds.com/company/nouscom)** Series D · CH · Revelation Partners **$135M** *Led*
- **Oct** **[Mueon Corp.](https://millionrounds.com/company/mueon-corp)** Series A · US · Pulse 2.0 **$65M** With 8 others
- **Aug** **[Quintessent](https://millionrounds.com/company/quintessent)** Series A · US · Ventureburn **$40M** With 12 others
- **2025** 3 rounds
- **Nov** **[Ferroelectric Memory Company (FMC)](https://millionrounds.com/company/ferroelectric-memory-company-fmc)** Growth · DE · DTCF DeepTech & Climate Fonds **$116M** With 6 others
- **Sept** **[NRG Therapeutics](https://millionrounds.com/company/nrg-therapeutics)** Series B · GB · Firms' own news pages **$68M** With 6 others
- **Jul** **[Actithera](https://millionrounds.com/company/actithera)** Series A · GB · 4BIO Capital **$76M** *Led*
- **2023** 1 round
- **Sept** **[CellFE](https://millionrounds.com/company/cellfe)** Series A · Elm Street Ventures **$22M** *Led*
- **2022** 2 rounds
- **Dec** **[Sonde Health](https://millionrounds.com/company/sonde-health)** Series B · US · Evidity Health Capital **$19M** With 4 others
- **Nov** **[Concerto Biosciences](https://millionrounds.com/company/concerto-biosciences)** Series A · US · Firms' own news pages **$23M** With 3 others
- **2019** 8 rounds
- **Dec** **[Neurable](https://millionrounds.com/company/neurable)** Series A · US · FinSMEs **$6.0M** *Led*
- **Nov** **[Immunitas](https://millionrounds.com/company/immunitas)** Series A · US · FinSMEs **$39M** With 4 others
- **Nov** **[FanAI](https://millionrounds.com/company/fanai)** Series A · US · Gamesindustry **$8.0M** With 7 others
- **Oct** **[Plexium](https://millionrounds.com/company/plexium)** Series A · US · Plexium **$28M** With 4 others
- **May** **[Altoida](https://millionrounds.com/company/altoida)** Series A · CH · FinSMEs **$6.3M** *Led*
- **May** **[DNA Script](https://millionrounds.com/company/dna-script)** Series B · FR · FinSMEs **$39M** With 6 others
- **Apr** **[Sonde](https://millionrounds.com/company/sonde)** US · Bioportfolio **$16M** Sole investor
- **Mar** **[Biolinq](https://millionrounds.com/company/biolinq)** Series A · US · FinSMEs **$4.8M** With 4 others
- **2018** 2 rounds
- **Nov** **[Ribometrix](https://millionrounds.com/company/ribometrix)** Series A · US · FinSMEs **$30M** *Led*
- **Aug** **[Artios](https://millionrounds.com/company/artios)** Series B · GB · FinSMEs **$83M** With 7 others
- **2017** 1 round
- **Nov** **[Wiliot](https://millionrounds.com/company/wiliot)** US · FinSMEs **$5.0M** With 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **4 named**

AM **Adrian Malik Fenty** Managing Member i Form ADV

CD **Charles David King** Managing Member i Form ADV

MR **Michael Richard Palank** Managing Member i Form ADV

MP **Mike Palank** Member of the General Partner i Filing they signed

We also hold **4** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$27M** gross assets of its funds Oct 2026

**Exempt** reporting adviser venture or small private funds

- **Legal name:** Macro Ventures LLC
- **SEC number:** CRD 296621

## What they claim to have backed

From their own portfolio page (on their website)

**0** of 6 we have independently watched raise

Canvasliving Creatrehub Elevaterei Thepinnaclecorp Varsityla Wyreco

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Latest fund on file

**Raised**

a fund in Jan 2018

From its SEC filing. Nothing newer is on file yet.

## The cheque

Series A Series B Growth

Median round joined **$29M** the round, not its cheque Alone, median **$16M**

Led 6 of 20 rounds **30%**

- **Sole investor:** 1 rounds
- **Last cheque:** Oct 2026

Rounds by stage said on their site

- Series A *12*
- Series B *4*
- Growth *1*
- Series D *1*

Cheques by month Led Joined

Dec 2023 Nov 2026

Often in the room with

- [AbbVie](https://millionrounds.com/fund/abbvie) 2
- [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 2
- [Andera Partners](https://millionrounds.com/fund/andera-partners) 2
- [Bpifrance](https://millionrounds.com/fund/bpifrance) 2
- [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) 2
- [Safar Partners](https://millionrounds.com/fund/safar-partners) 2

**Pitching M/VENTURES?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as M/VENTURES. A count of rooms they were both in, not a relationship either has claimed.

[**AbbVie** Corporate VC **2** rounds together](https://millionrounds.com/fund/abbvie)[**Alexandria Real Estate Equities** VC firm **2** rounds together](https://millionrounds.com/fund/alexandria)[**Andera Partners** Private equity **2** rounds together](https://millionrounds.com/fund/andera-partners)[**Bpifrance** Government **2** rounds together](https://millionrounds.com/fund/bpifrance)[**Novartis Venture Fund** Corporate VC **2** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**Safar Partners** VC firm **2** rounds together](https://millionrounds.com/fund/safar-partners)

## Recently backed

The latest companies M/VENTURES put money into.

[**Nouscom** $135M · Oct 2026](https://millionrounds.com/company/nouscom)[**Quintessent** $40M · Aug 2026](https://millionrounds.com/company/quintessent)[**NRG Therapeutics** $68M · Sept 2025](https://millionrounds.com/company/nrg-therapeutics)[**Actithera** $76M · Jul 2025](https://millionrounds.com/company/actithera)[**CellFE** $22M · Sept 2023](https://millionrounds.com/company/cellfe)[**Concerto Biosciences** $23M · Nov 2022](https://millionrounds.com/company/concerto-biosciences)

## Quick answers about M/VENTURES

### What does M/VENTURES invest in?

M/VENTURES invests most often at Series A and Series B (89% of the rounds on record), in sectors such as Venture Capital & Private Equity.

### How active is M/VENTURES?

20 investments on record, 4 of them in the last 12 months, and it led 6. The most recent was in Oct 2026.

### What has M/VENTURES invested in recently?

Its most recent investments on record: Nouscom (Series D, Oct 2026), Mueon Corp. (Series A, Oct 2026) and Quintessent (Series A, Aug 2026).

### How big are M/VENTURES's cheques?

The median round it joins is $29M.

### Does M/VENTURES lead rounds?

Yes: it led 6 of its 20 investments on record (30%).

### Where does M/VENTURES invest?

Most of the companies it backs are in the United States (63%), the United Kingdom (16%) and Switzerland (11%).

### Is M/VENTURES investing now?

Yes: it is actively investing, with 4 investments in the last 12 months.

### Who does M/VENTURES invest alongside?

Most often AbbVie (2 rounds together), Alexandria Real Estate Equities (2 rounds together) and Andera Partners (2 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=m-ventures-6) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=m-ventures-6)